Работы, на которые ссылается эта работа

Работ: 177

Работа: Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects

DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes
Yui Hatanaka, Takeshi Niinuma, Hiroshi Kitajima +15
Статья2021Цитирований: 2
ABI
Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN/STAT1 signaling pathway
Yongcan Xu, Jun Lu, Neng Lou +4
Статья2022Цитирований: 2
ABI
Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA
Ying Zhang, Meiying Luo, Xiaohong Cui +2
Статья2022Цитирований: 2
ABI
Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling
Siyu Liu, Xiyi Chen, Ke Huang +9
Статья2022Цитирований: 2
ABI
circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment
Roberta Piras, Emily Ko, Connor Barrett +13
Статья2022Цитирований: 2
ABI
LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axis
Qin Wang, Guozheng Li, Xin Ma +10
Статья2023Цитирований: 2
ABI
A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
Nan Ding, A‐Bin You, Hu Yang +4
Статья2023Цитирований: 2
ABI
CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity
Lulu Yu, Qi Xiao, Bing Yu +3
Обзорная статья2023Цитирований: 2
ABI
Exploring the regulatory role of lncRNA in cancer immunity
Danting Zhan, Hong-chun Xian
Обзорная статья2023Цитирований: 2
ABI
Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells
Aisha Farhana, Abdullah Alsrhani, Naila Rasheed +1
Статья2023Цитирований: 2
ABI
LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway
Lin Du, Baojun Wang, Mengtong Wu +8
Статья2023Цитирований: 2
ABI
Engineered nanoparticles promote cardiac tropism of AAV vectors
Lauren Switala, Lin Di, Huiyun Gao +5
Статья2024Цитирований: 2
ABI
NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis
Zimu Wang, Jing Luo, Hairong Huang +12
Статья2024Цитирований: 2
ABI
lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin
Xiaoyan Yin, Haizhong Zhang, Jingmiao Wang +4
Статья2024Цитирований: 2
ABI
ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma
Haoyuan Xu, Wanpeng Li, Kai Xue +9
Статья2024Цитирований: 2
ABI
Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response
Kim Denise Fischer, Shashank Tiwari, Beatrice Thier +4
Статья2024Цитирований: 2
ABI
HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer
Hayato Nishiyama, Takeshi Niinuma, Hiroshi Kitajima +9
Статья2024Цитирований: 2
ABI
The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA
Brian Lara, Megan Snyder, Jocelyn Fimbres +5
Статья2025Цитирований: 2
ABI
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan +6
Обзорная статья2020Цитирований: 2
ABI
Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application
Le Zhang, Xiaonan Xu, Xiulan Su
Обзорная статья2020Цитирований: 2
ABI
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment
Raffaele De Luca, Luca Gianotti, Paolo Pedrazzoli +13
Обзорная статья2022Цитирований: 2
ABI
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Matteo Santoni, Sebastiano Buti, Zin Myint +63
Статья2023Цитирований: 2
ABI
CAR-engineered cell therapies: current understandings and future perspectives
Mobina Bayat, Javid Sadri Nahand
Статья2026Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI